Search This Blog

Friday, April 14, 2023

ResMed: Mizuho Securities initiated coverage with a recommendation of buy.

 

  •  PT up 13% to $255.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)